DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Expected to Earn Q2 2024 Earnings of $0.51 Per Share

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Analysts at William Blair reduced their Q2 2024 EPS estimates for DENTSPLY SIRONA in a note issued to investors on Tuesday, June 25th. William Blair analyst B. Vazquez now anticipates that the medical instruments supplier will post earnings of $0.51 per share for the quarter, down from their previous estimate of $0.52. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $2.02 per share. William Blair also issued estimates for DENTSPLY SIRONA’s Q3 2024 earnings at $0.51 EPS, Q4 2024 earnings at $0.55 EPS, FY2024 earnings at $1.99 EPS and FY2025 earnings at $2.32 EPS.

Other equities analysts have also issued reports about the stock. Barrington Research lowered their price target on shares of DENTSPLY SIRONA from $41.00 to $38.00 and set an “outperform” rating on the stock in a research report on Friday, May 3rd. StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday, May 3rd. Evercore ISI lowered their price target on shares of DENTSPLY SIRONA from $35.00 to $28.00 and set an “outperform” rating on the stock in a research report on Tuesday. Piper Sandler restated a “neutral” rating and set a $32.00 price target (down from $35.00) on shares of DENTSPLY SIRONA in a research report on Friday, May 3rd. Finally, Needham & Company LLC lowered their price target on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating on the stock in a research report on Friday, May 3rd. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $34.44.

DENTSPLY SIRONA Stock Up 0.6 %

XRAY opened at $25.16 on Wednesday. DENTSPLY SIRONA has a fifty-two week low of $24.82 and a fifty-two week high of $41.65. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.97 and a current ratio of 1.43. The company has a fifty day moving average of $27.94 and a two-hundred day moving average of $31.81. The stock has a market capitalization of $5.22 billion, a price-to-earnings ratio of -57.18, a PEG ratio of 1.12 and a beta of 1.04.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company had revenue of $953.00 million during the quarter, compared to analysts’ expectations of $969.45 million. During the same quarter in the previous year, the company earned $0.39 earnings per share. The firm’s revenue for the quarter was down 2.6% on a year-over-year basis.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several large investors have recently added to or reduced their stakes in the business. Parkside Financial Bank & Trust increased its stake in DENTSPLY SIRONA by 33.3% during the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock worth $42,000 after buying an additional 292 shares during the period. Beach Investment Counsel Inc. PA increased its stake in DENTSPLY SIRONA by 1.4% during the 4th quarter. Beach Investment Counsel Inc. PA now owns 22,125 shares of the medical instruments supplier’s stock worth $787,000 after buying an additional 306 shares during the period. Wahed Invest LLC increased its stake in DENTSPLY SIRONA by 9.3% during the 4th quarter. Wahed Invest LLC now owns 3,603 shares of the medical instruments supplier’s stock worth $128,000 after buying an additional 306 shares during the period. VisionPoint Advisory Group LLC increased its position in shares of DENTSPLY SIRONA by 104.2% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock valued at $26,000 after purchasing an additional 395 shares during the last quarter. Finally, Treasurer of the State of North Carolina increased its position in shares of DENTSPLY SIRONA by 0.5% in the 3rd quarter. Treasurer of the State of North Carolina now owns 92,842 shares of the medical instruments supplier’s stock valued at $3,171,000 after purchasing an additional 470 shares during the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier acquired 3,577 shares of the firm’s stock in a transaction dated Friday, May 31st. The shares were purchased at an average cost of $27.95 per share, for a total transaction of $99,977.15. Following the acquisition, the director now owns 58,374 shares in the company, valued at approximately $1,631,553.30. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 12th. Stockholders of record on Friday, June 28th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $0.64 annualized dividend and a dividend yield of 2.54%. DENTSPLY SIRONA’s dividend payout ratio is currently -145.45%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.